TABLE 3.
Oligonucleotide primers used in this study
| Gene ampli- fied | Product size (kb) | Primer set | Sequencea |
|---|---|---|---|
| rfbD | 2.5 | rfbD F | 5′-GTGGAATGGTATCTGTC-3′ |
| rfbD R | 5′-TTGTGTTATAGATGTGC-3′ | ||
| rol | 0.7 | rol F | 5′-TGGCAAGATGACAATT-3′ |
| rol R | 5′-AAGTTTATCTCAACGTCAAG-3′ | ||
| ugd | 1.1 | ugd F | 5′-CCGTCACGCGTTGCTATGCTG-3′ |
| ugd R | 5′-TTGGATCCCCGTGAATGCTATAGG-3′b | ||
| his | 0.8 | his F | 5′-TAGGATCCCCGAAGAAAGCAATTCCTTG-3′b |
| his R | 5′-TATCTAGACGGGCAATTTCCTCAATG-3′c | ||
| kfiC | 3.2 | kfiC F | 5′-GGGAAGCTCTATTCTCAGTCGACG-3′d |
| kfiD R | 5′-CGCGACTATAGACTTTGTCGACC-3′d |
Sequences complementary to gene amplified are in boldface.
BamHI sites are underlined.
XbaI sites are underlined.
SalI sites are underlined.